Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, W. R.
Right arrow Articles by Macias, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, W. R.
Right arrow Articles by Macias, W. L.

Journal of the American Society of Nephrology, Vol 8, 804-812, Copyright © 1997 by American Society of Nephrology


REGULAR ARTICLES

Extracorporeal therapy requirements for patients with acute renal failure

WR Clark, BA Mueller, MA Kraus and WL Macias
Renal Division, Baxter Healthcare Corp., McGaw Park, Illinois 60085, USA.

Renal replacement therapy (RRT) requirements for critically ill patients with acute renal failure (ARF) depend on numerous factors, including the degree of hypercatabolism, patient size, and desired level of metabolic control. However, the current practice at many institutions is to prescribe generally similar amounts of RRT to ARF patients essentially without regard for the above factors. In this study, a computer-based model designed to permit individualized RRT prescription to ARF patients was developed. The critical input parameter is the desired level of metabolic control, which is the time- averaged BUN (BUNa) or steady-state BUN (BUNs) for intermittent hemodialysis (IHD) or continuous RRT (CRRT), respectively. The basis for the model was a group of 20 patients who received uninterrupted CRRT for at least 5 days. In these patients, the normalized protein catabolic rate (nPCR) increased linearly (r = 0.974) from 1.55 +/- 0.14 g/kg per day (mean +/- SEM) on day 1 to 1.95 +/- 0.15 g/kg per day on day 6. The daily urea generation rate (G), determined from the above linear relationship, was utilized to produce BUN versus time curves by the direct quantification method for simulated patients of varying dry weights (50 to 100 kg) who received variable CRRT urea clearances (500 to 2000 ml/h). Steady-state BUN versus time profiles for the same simulated patient population treated with IHD regimens (K = 180 ml/min, T = 4 h) of variable frequency were generated by use of a variable- volume, single-pool kinetic model. From these profiles, regression lines of required IHD frequency (per week) versus patient weight for desired BUNa values of 60, 80, and 100 mg/dl were obtained. Regression lines of required CRRT urea K (ml/h) versus patient weight for desired BUNs values of 60, 80, and 100 mg/dl were also generated. For the attainment of intensive IHD metabolic control (BUNa = 60 mg/dl) at steady state, a required treatment frequency of 4.4 dialyses per week is predicted for a 50-kg patient. However, the model predicts that the same degree of metabolic control cannot be achieved even with daily IHD therapy in patients > or = 90 kg. On the other hand, for the attainment of intensive CRRT metabolic control (BUNs = 60 mg/dl), required urea clearance rates of approximately 900 ml/h and 1900 ml/h are predicted for 50- and 100-kg patients, respectively. This model suggests that, for many patients, rigorous azotemia control equivalent to that readily attainable with most CRRT can only be achieved with intensive IHD regimens. Following prospective clinical validation, this methodology may be a useful RRT prescription tool for critically ill ARF patients.


This article has been cited by other articles:


Home page
J Intensive Care MedHome page
G. S. Teehan, O. Liangos, and B. L. Jaber
Update on Dialytic Management of Acute Renal Failure
J Intensive Care Med, May 1, 2003; 18(3): 130 - 138.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. VANHOLDER, W. V. BIESEN, and N. LAMEIRE
What Is the Renal Replacement Method of First Choice for Intensive Care Patients?
J. Am. Soc. Nephrol., February 1, 2001; 12(90001): S40 - S43.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. MURRAY and J. HALL
Renal Replacement Therapy for Acute Renal Failure
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 777 - 781.
[Full Text]


Home page
Nephrol Dial TransplantHome page
N. Lameire, W. Van Biesen, and R. Vanholder
Dialysing the patient with acute renal failure in the ICU: the emperor's clothes?
Nephrol. Dial. Transplant., November 1, 1999; 14(11): 2570 - 2573.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. S. Kanagasundaram and E. P. Paganini
Critical care dialysisa Gordian knot (but is untying the right approach?)
Nephrol. Dial. Transplant., November 1, 1999; 14(11): 2590 - 2594.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP